Article

Farnesyl Transferase Inhibition for the Treatment of Tauopathies

medRxiv · 2018 · Hernandez, I.; Luna, G.; Rauch, J. N.; Giroux, M.; Karch, C. M.; Boctor, D.; Storm, N. J.; Diaz, A.; Zekanowski, C.; Kang, A. A.; Hinman, C.; Cerovac, V.; Guzman, E.; Zhou, H.; Goate, A.; Fisher, S. K.; Cuervo, A. M.; Kosik, K. S.

Key facts

Title Farnesyl Transferase Inhibition for the Treatment of Tauopathies
First author Hernandez, I.; Luna, G.; Rauch, J. N.; Giroux, M.; Karch, C. M.; Boctor, D.; Storm, N. J.; Diaz, A.; Zekanowski, C.; Kang, A. A.; Hinman, C.; Cerovac, V.; Guzman, E.; Zhou, H.; Goate, A.; Fisher, S. K.; Cuervo, A. M.; Kosik, K. S.
Journal medRxiv
Published Dec 18, 2018
DOI 10.1101/500801
Devices mentioned BK110039
Product codes mentioned KIP, KIT, NDS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature